BioCentury
ARTICLE | Company News

Management tracks: Ginkgo Bioworks, KSQ, Milestone, Cerebral

April 16, 2019 11:16 PM UTC

Genetic engineering company Ginkgo Bioworks Inc. (Boston, Mass.) appointed Marijn Dekkers as chairman and strategic adviser. He was CEO of Bayer AG (Xetra:BAYN) and is currently chairman of Unilever plc (LSE:ULVR), Unilever N.V. (NYSE:UL) and investment and advisory firm Novalis LifeSciences LLC (Hampton, N.H.).

KSQ Therapeutics Inc. (Cambridge, Mass.) hired Beni Wolf as its first CMO. He was SVP, clinical development at Blueprint Medicines Corp. (NASDAQ:BPMC). KSQ is developing therapies using its CRISPRomics technology to identify cancer and immuno-oncology targets by screening all human genes in cancer cell lines and T cells (see "KSQ: Widescreen CRISPR")...